Policy

Abbott Must Face Lawsuit Over PediaSure Growth Claims

By Intent.Health Team June 4, 2026
Intent Health AI Data Flow

What's happening

A federal judge ruled that Abbott Laboratories must face a proposed class-action lawsuit alleging that its PediaSure Grow & Gain drinks misled consumers into believing they were clinically proven to help children grow taller.

The judge found that product packaging, advertising, and marketing materials could reasonably lead consumers to interpret "growth" as increased height rather than general nutrition.

What's changing / Business impact

The ruling allows the lawsuit to proceed and could increase scrutiny of how healthcare and nutrition products are marketed to parents.

Companies may become more cautious about health-related advertising claims.

Why this matters

Parents often rely on product labels and advertising when making decisions about their children's nutrition.

Courts generally take a close look at whether marketing language could create unrealistic expectations or mislead consumers.

The case does not determine whether Abbott did anything wrong, but it allows the allegations to be examined further in court.